FDA Action Alert: Adamas, Mallinckrodt and Merck

February is kicking off with a number of PDUFA dates for the U.S. Food and Drug Administration (FDA) as well as a cancer advisory committee meeting. Here’s a look.

Adamas Pharmaceuticals’ Gocovri for OFF Episodes in Parkinson’s